Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies to Report Financials Around Realigned Business Groups

NEW YORK (GenomeWeb News) – Life Technologies will be reporting its financial results in three new business groups to better reflect its internal organization and end markets, the company said in a regulatory filing after the close of the market on Wednesday.

Starting with the first quarter ended March 31, Life Tech's financial results will be reported for Research Consumables, Genetic Analysis, and Applied Sciences. Results had been grouped around the firm's technology platforms Molecular Biology Systems, Genetic Systems, and Cell Systems.

The changes have no impact on consolidated results of operations, financial conditions, or cash flow, Life Tech said in the document filed with the US Securities and Exchange Commission.

Life Tech's first-quarter earnings results are scheduled to be announced after the close of the market on April 24.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.